Highlights from the American Diabetes Association annual meeting for PCPs
A potential new treatment for type 1 diabetes, an analysis of cardiovascular outcome trials for patients with the condition and how to treat diabetes in youth, were some of the top takeaways from this year’s American Diabetes Association meeting, according to an interview with an ADA member.
Kim Pfotenhauer, DO, assistant professor of primary care at Touro University, California,
discussed the meeting’s highlights with Healio Family Medicine.
Among the most significant presentations was data about a dual SGLT1 and SGLT2 inhibitor for treating type 1 diabetes, which Pfotenhauer described as “interesting.”
Copyright 2005 - 2019, Touro University, All Rights Reserved.